InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Latest patents news RSS Feed

  • Orrick further bolsters Taiwan outbound practice

    E Patrick Ellisen has moved to Orrick's Silicon Valley office

  • Top IP judges discuss role of judiciary in promoting business

    Getting it right or making it predictable? That's one of the big challenges that IP judges face when deciding cases

  • Interview: Tong Xin of ZTE

    Tong Xin, senior licensing director at ZTE, tells Managing IP why he thinks doing business in China is not that different from other countries and what legal developments he is tracking

  • Proposed PTAB changes aim to increase balance

    PTAB observers have reacted to USPTO’s extensive set of proposed rule changes, noting patent owners will benefit from proposals such as allowing testimonial evidence in their preliminary response. The USPTO has followed up the rule changes by also suggesting a pilot programme of having a single judge determine whether to institute an IPR

  • The seven disruptors that are changing IP practice

    The IP legal market is changing. In-house counsel want more for less, technology is commoditising work processes and the partnership track is becoming less attractive to growing numbers of lawyers. Emma Barraclough considers the influences that are reshaping the market. Plus: those shaping the changes make their predictions for the future

  • Recent guidance on SEP licensing in the US and EU

    Two decisions in Europe and the United States have addressed the licensing of standard- essential patents. Andrew Moir, David Wilson, Nic Ruesink- Brown, Joseph Falcone and Allison Alcasabas ask: have the courts provided a helping FRAND?

  • Two Bass IPRs fail at PTAB but more cases filed

    The PTAB has declined to institute inter partes reviews brought against two of Acorda Therapeutic's patents covering its multiple-sclerosis drug, finding that the posters cited in evidence did not qualify as prior art

  • US and China IP experts call for reforms to boost Chinese pharmaceutical industry

    The US-China IP Cooperation Dialogue Report says that greater protection for innovators is needed to unleash the potential of China's pharmaceutical industry

Most read articles

Latest Country Updates